Robotic Vial Filling and Capping Machine under Isolator
Steriline is an expanding European manufacturer founded in the Lake Como area in 1989, highly specialized in the production of complete lines for the aseptic processing of injectable products, supplying pharmaceutical companies worldwide.
STERILINE is proud to introduce its new Robotic Vial Filling and Capping Machine for injectable products fully under in-house engineered and manufactured Isolators integrated with the latest VHP technology.
The machine was designed and manufactured jointly with the German pharmaceutical company AqVida.
The key features are:
- 3 VHP resistant robotic arms from STÄUBLI Robotics based in Switzerland
- Peristaltic pumps actuated by servomotors, that allow precise filling and easy adjustment of the pumps by means of the HMI
- “No loss / zero waste philosophy” resulting in all missing stoppers / caps being collected and re-applied during the process
- 100% in-line Check Weighing System integrated in the filling station
- The vials range that can be treated goes from 2ml to 100ml, without changing any format parts, with an estimated output of approx. 6.000 vials/h satisfying at the best the customer requirements in terms of flexibility on the one hand and efficiency on the other
The line is installed in the new AqVida plant in Dassow.
Contact details:
Company name: Steriline Srl
Website: www.steriline.it
E-mail: ref="mailto:mirko.monti@steriline.it">mirko.monti@steriline.it
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
